AIC468, a Novel Antisense Oligonucleotide in Clinical Development for the Treatment of BKV in Kidney Transplant Recipients: Evidence of Broad BKV Strain Coverage and a Low Probability of Pre‑Existing Drug Resistance (IDWeek 2026) - Sep 6, 2026 - Abstract #P - 2076; Pres time: Oct 24, 2026; 12:15 PM - 01:30 PM; Location: Poster Hall B-C; No abstract available
Clinical • Infectious Disease
|
|
Angelica Lorenzo, n/a; Jurrien Prins, n/a; Eric Van der Veer, n/a; Peter Lischka, PhD (he/him/his)
|